|
Truth
is powerful and inbodies those who seek it with an open mind. |
|
|
Source:
Source:
Pro-Life Infonet
Washington,
DC
|
Date
October 22, 2000 |
- In the aftermath of the FDA's decision to authorize
the use of the dangerous abortion drug RU 486, abortion
facilities and health centers in various states and
localities are deciding whether or not to dispense the
abortion drug. In Michigan, while the University of
Michigan's Health Service is still planning on not offering
RU-486, there are still local options for obtaining
the abortion drug. UHS Interim Director Robert Winfield
said UHS plans to provide "options counseling" for students
considering taking the drug. The counseling would be
a "neutral non-moral" review of the choices an individual
has when she is pregnant. UHS will also refer women
to further counseling such as Counseling and Psychological
Services. The University Hospitals and Planned Parenthood
of Ann Arbor are also planning to dispense RU 486, but
they do not have a definite idea of when they will begin
prescribing the pill. Winfield said the only school
in the Big Ten considering disepnsing Ru 486 is the
University of Wisconsin at Madison. Scott Spear, clinical
director at Wisconsin's University Health Services,
said the question is whether dispensing RU 486 is a
needed service when there are various abortion facilities
that could. "Most Big Ten schools are in big cities
and so universities won't be able to provide a lower
cost or significant advantage to students by distributing
mifepristone," Spear said, adding that if there was
significant support from Wisconsin students, the school
would probably disepnse RU 486. Wisconsin is at a slight
disadvantage for disepnsing RU 486, Spear said. Other
health centers such as the University's may have access
to ultrasound equipment to determine the age of pregnancy,
while Wisconsin does not. Meanwhile, the Louisiana State
University Student Health Center will not disepnse RU
486 because the center does not have the equipment necessary
to safely administer the drug. The Health Center staff
met to discuss the issue and become familiar with information
about the abortion pill before deciding not to offer
it, said Dr. Timothy Honigman, chief of staff for the
Student Health Center. "We tried to make a medical decision,
and that's what we've done," Honigman said. In order
to disepnse RU 486 someone must determine if a woman
is still in the first 49 days of pregnancy, he said.
To accurately determine a date, doctors must perform
an ultrasound, he said. "We don't have that," Honigman
said. In addition to ultrasound equipment, the Health
Center would also need to handle surgical emergencies
in order to prescribe the drug, he said. "Some women
will have excessive bleeding that will require surgery
to correct," Honigman said. Health Center doctors do
not have the equipment to perform emergency surgery,
he said. "We are not a surgical facility," Honigman
said. Since the Food and Drug Administration approved
the pill, the Health Center doctors have not received
any requests or inquiries from patients about RU-486,
Honigman said. In Massachusetts, administrators at Harvard's
University Health Services (UHS) remain undecided over
whether to have Ru 486. According to UHS Director Dr.
David S. Rosenthal, UHS "will be following the advice
of the gynecologists at the Brigham and Women's Hospital
in Boston" as to whether and how it should be offered.
It is possible that students could receive RU 486 through
the UHS pharmacy. Students "with strong moral objections
to sharing the cost of elective abortions" can apply
for a refund of the portion of their $1 fee used for
this purpose. The option, outlined in the Guide to UHS,
was exercised by 271 students last year. In New Jersey,
one lawmaker wants taxpayer funds to cover the costs
for state employees who want RU 486. Pro-abortion assemblyman
Neil Cohen, D-Union, wrote to the state Division of
Pensions and Benefits seeking the addition of the dangerous
abortion drug in the state Health Benefits Plan. State
approval would send a signal to private insurance companies
that they, too, should cover the pill's cost, the lawmaker
said. |
|
|
|
|
|
|